The First International Pharmaceutical Compliance Congress and Best Practices Forum was held in Brussels in June 2007 to bring together company compliance professionals, regulators, lawyers, and consultants working in this interesting and expanding field. The purpose was to hold a truly global conference, addressing the key issues of the day. The first international conference agenda was mainly developed by company compliance professionals around topics that they wanted to know more about, which is one of the great strengths of these conferences and continues to be one of their key features.
In addition to Brussels, other international conferences have been held in Paris (2008), Rome (2009), Berlin (2010), Istanbul (2011), Budapest (2012) and Madrid (2013). Over the years the international conference agendas have developed to focus particular streams on the European Union (EU), Central and Eastern Europe (CEE ), and Middle East and Africa (MEA), in addition to plenary sessions on global topics. The 2015 conference continues this trend.
In 2015 we are pleased to return to Brussels. The Ninth International Pharmaceutical Compliance Congress and Best Practices Forum will address the leading pharmaceutical and medical device ethics and compliance issues in the European Union (EU) and include updates from Central and Eastern Europe (CEE), the Middle East and Africa (MEA) and India. The Congress will feature the following plenary sessions and mini summits:
|
FEATURING PLENARY SESSIONS
|
- Keynote Address: Innovation, Ethics and Compliance
- Keynote Address: The C-Suite Perspective
- European Commission Keynote Address
- Transparency International Keynote Address
- Global Chief Compliance Officer Roundtable
- Understanding the New Life Sciences Marketplace
- The New Marketplace: The Purchasers Perspective
- Roundtable on Compliance Issues Raised by the Changing Marketplace
- IFPMA International Codes Update
- Global Transparency Roundtable
- Anticorruption 2.0: Thinking Strategically/Managing Risks
- Crafting the Compliance Program of the Future
- The Evolution of the Role and Responsibility of Compliance Professionals
|
|
|
AND MINI SUMMITS
|
- I: Basic Compliance Concepts and Skills I
- II: How to Engage with Medical Societies and Congress Organizers in Order to Ensure that Industry Standards are Understood and Taken into Consideration
- III: Competition/Antitrust Law Update
- IV: Global Transparency, Disclosure and Aggregate Spend Update
- V: Annual Central and Eastern European (CEE) Compliance Update
- VI: Basic Compliance Concepts and Skills II
- VII: Global Compliance Auditing and Monitoring Best Practices
- VIII: What’s Next in Global Compliance?
- IX: Clinical Trials Compliance
- X: Data Analytics Supporting Compliance Monitoring, Risk Prevention and Mitigation
- XI: Advanced Strategies in Compliance Training
- XII: Annual Middle East/Africa European (MEA) Compliance Update
- XIII: Medical Device Compliance Issues Update
- XIV: Advanced Issues in Anti-corruption Compliance
- XV: Best Practices in Third Party Supplier Management
|
|
In 2013 the new International Society of Healthcare Ethics and Compliance Professionals (ethics) has become the Congress sponsor and the Pharmaceutical Compliance Forum (PCF) has become the Congress co-sponsor.
